Capital Research Global Investors’s New Frontier Health Corporation Ordinary Shares NFH Stock Holding History
Bought
Maintained
Sold
Other funds holding NFH
Capital Research Global Investors's NFH Position: Q1 2022 in Review
Capital Research Global Investors sold out of New Frontier Health Corporation Ordinary Shares (NFH) in Q1 2022, closing a stake of 6,233,657 shares — an estimated $71.4M sold.
Capital Research Global Investors first reported a position in NFH in Q4 2019 and held it in 9 quarters. The position peaked at $138M in Q1 2021. 2 funds tracked by Wall St. Rank hold NFH as of Q1 2022.
- Capital Research Global Investors reported no remaining New Frontier Health Corporation Ordinary Shares position as of Q1 2022 after selling out during the quarter.
- Capital Research Global Investors sold 6,233,657 New Frontier Health Corporation Ordinary Shares shares in Q1 2022, an estimated $71.4M.
- Capital Research Global Investors first reported a position in New Frontier Health Corporation Ordinary Shares in Q4 2019 and held it in 9 quarters.
- Capital Research Global Investors's New Frontier Health Corporation Ordinary Shares position peaked at $138M in Q1 2021.
- 2 funds tracked by Wall St. Rank held New Frontier Health Corporation Ordinary Shares as of Q1 2022.
Based on Capital Research Global Investors's 13F filing for Q1 2022, filed 16 May 2022.